Structure degradation and strength changes of sintered calcium phosphate bone scaffolds with different phase structures during simulated biodegradation in vitro.


Journal

Materials science & engineering. C, Materials for biological applications
ISSN: 1873-0191
Titre abrégé: Mater Sci Eng C Mater Biol Appl
Pays: Netherlands
ID NLM: 101484109

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 28 12 2018
revised: 05 03 2019
accepted: 08 03 2019
entrez: 6 4 2019
pubmed: 6 4 2019
medline: 26 7 2019
Statut: ppublish

Résumé

The structure degradation and strength changes of calcium phosphate scaffolds after long-term exposure to an acidic environment simulating the osteoclastic activity were determined and compared. Sintered calcium phosphate scaffolds with different phase structures were prepared with a similar cellular pore structure and an open porosity of over 80%. Due to microstructural features the biphasic calcium phosphate (BCP) scaffolds had a higher compressive strength of 1.7 MPa compared with the hydroxyapatite (HA) and β-tricalcium phosphate (TCP) scaffolds, which exhibited a similar strength of 1.2 MPa. After exposure to an acidic buffer solution of pH = 5.5, the strength of the HA scaffolds did not change over 14 days. On the other hand, the strength of the TCP scaffolds decreased steeply in the first 2 days and reached a negligible value of 0.09 MPa after 14 days. The strength of the BCP scaffolds showed a steady decrease with a reasonable value of 0.5 MPa after 14 days. The mass loss, phase composition and microstructural changes of the scaffolds during degradation in the acidic environment were investigated and a mechanism of scaffold degradation was proposed. The BCP scaffold showed the best cell response in the in vitro tests. The BCP scaffold structure with the highly soluble phase (α-TCP) embedded in a less soluble matrix (β-TCP/HA) exhibited a controllable degradation with a suitable strength stability and with beneficial biological behavior it represented the preferred calcium phosphate structure for a resorbable bone scaffold.

Identifiants

pubmed: 30948091
pii: S0928-4931(18)33971-7
doi: 10.1016/j.msec.2019.03.027
pii:
doi:

Substances chimiques

Calcium Phosphates 0
DNA 9007-49-2

Types de publication

Journal Article

Langues

eng

Pagination

544-553

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Premysl Stastny (P)

CEITEC BUT, Brno University of Technology, Purkynova 123, 612 00 Brno, Czech Republic.

Radek Sedlacek (R)

Department of Mechanics, Biomechanics and Mechatronics, Czech Technical University in Prague, Technicka 4, 166 07 Prague, Czech Republic.

Tomas Suchy (T)

Department of Mechanics, Biomechanics and Mechatronics, Czech Technical University in Prague, Technicka 4, 166 07 Prague, Czech Republic; Institute of Rock Structure and Mechanics, Czech Academy of Sciences, V Holesovickach 41, 182 09 Prague, Czech Republic.

Vera Lukasova (V)

Institute of Experimental Medicine, Czech Academy of Sciences, Videnska 1083, 142 20 Prague, Czech Republic; University Center for Energy Efficient Buildings, Czech Technical University in Prague, Trinecka 1024, 273 43 Bustehrad, Czech Republic; Department of Cell Biology, Charles University, Vinicna 5, 128 00 Prague, Czech Republic.

Michala Rampichova (M)

Institute of Experimental Medicine, Czech Academy of Sciences, Videnska 1083, 142 20 Prague, Czech Republic.

Martin Trunec (M)

CEITEC BUT, Brno University of Technology, Purkynova 123, 612 00 Brno, Czech Republic; Institute of Materials Science and Engineering, Brno University of Technology, Technicka 2, 616 69 Brno, Czech Republic. Electronic address: martin.trunec@ceitec.vutbr.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH